Cover Image

Chinese Herbal Medicine for Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Objectives: To evaluate the efficacy and safety of Chinese herbal medicine (CHM) for type 2 diabetes mellitus (T2DM) with nonalcoholic fatty liver disease (NAFLD) with current evidence.Methods: This study was registered in PROSPERO as CRD42021271488. A literature search was conducted in eight electr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sihan Peng (Author), Lu Liu (Author), Ziyan Xie (Author), Xiyu Zhang (Author), Chunguang Xie (Author), Sha Ye (Author), Xiangeng Zhang (Author), Xiaoli Liang (Author), Hongyan Wang (Author), Ya Liu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of traditional Chinese medicine external washing in the treatment of postoperative wound of diabetes complicated with anal fistula: Study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial
by: Jian Kang, et al.
Published: (2022)

Chinese herbal medicine combined with western medicine for the treatment of type 2 diabetes mellitus with hyperuricemia: A systematic review and meta-analysis
by: Hongyan Liu, et al.
Published: (2023)

Effect of microplastics on nasal and intestinal microbiota of the high-exposure population
by: Xiyu Zhang, et al.
Published: (2022)

Effect of Huang-Lian Jie-Du Decoction on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
by: Zhipeng Hu, et al.
Published: (2021)

Combination of traditional Chinese medicine and standard biomedical treatment for rosacea: a systematic review and a meta-analysis
by: Ruoxi Yu, et al.
Published: (2024)

Efficacy and safety of Danggui Niantong Decoction in patients with gout: a systematic review and meta-analysis
by: Sihan Peng, et al.
Published: (2023)

Identification of key genes increasing susceptibility to atrial fibrillation in nonalcoholic fatty liver disease and the potential mechanisms: mitochondrial dysfunction and systemic inflammation
by: Baiyin Zhong, et al.
Published: (2024)

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
by: Tingting Yan, et al.
Published: (2020)

The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials
by: Zehua Zhang, et al.
Published: (2023)

Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
by: Xiao-Fang Yang, et al.
Published: (2021)

Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
by: Huixia Liu, et al.
Published: (2022)

The relationship between folic acid and nonalcoholic fatty liver disease
by: Bing'er Xu, et al.
Published: (2024)

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice
by: Qin-Juan Sun, et al.
Published: (2021)

Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity
by: Luting Peng, et al.
Published: (2021)

Editorial: Nonalcoholic fatty liver disease: From pathogenesis to phytomedicine based on omics technology
by: Guang Ji, et al.
Published: (2022)

Efficacy and mechanism of Shenqi Compound in inhibiting diabetic vascular calcification
by: Chan Yang, et al.
Published: (2023)

Nonalcoholic Fatty Liver Disease An Update
Published: (2019)

Endoplasmic reticulum stress response in nonalcoholic fatty liver disease
by: Arushana Ali, et al.
Published: (2018)

Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus
by: Yanbo Fan, et al.
Published: (2018)

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
by: Yuting Ma, et al.
Published: (2021)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023)

Wendan decoction in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis
by: Yufeng Zhang, et al.
Published: (2022)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019)

Nonalcoholic Fatty Liver Disease and Ayurveda
by: Sanjeev Sharma, et al.
Published: (2023)

Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver
by: Feng Y, et al.
Published: (2022)

Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease
by: Xue-Kai Wang, et al.
Published: (2021)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
by: Hu Li, et al.
Published: (2022)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
by: Yuzhen Zhao, et al.
Published: (2019)

Fatty liver in a child: Looking beyond nonalcoholic fatty liver disease
by: Jaya Agarwal, et al.
Published: (2021)

Nonalcoholic fatty liver disease in children and adolescents
by: Hae Sang Lee
Published: (2024)

Nonalcoholic fatty liver disease: New epidemic
by: Rajkumar P Wadhwa, et al.
Published: (2021)

Nonalcoholic fatty liver disease and portal hypertension
by: Marvin Ryou, et al.
Published: (2020)

Editorial: Nonalcoholic fatty liver disease therapy: Exploring molecular mechanisms of well-defined composition from natural plants
by: Wenji Zhang, et al.
Published: (2022)

Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes
by: He WX, et al.
Published: (2017)

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
by: ChenLu Zhao, et al.
Published: (2023)

Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease
by: Guangyu Jiang, et al.
Published: (2020)

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
by: Yuan-Ye Qiu, et al.
Published: (2023)

Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis
by: Shan Tang, et al.
Published: (2020)

Prospective cohort study of Helicobacter pylori infection on the risk of nonalcoholic fatty liver disease
by: Changxi Chen, et al.
Published: (2024)